29 related articles for article (PubMed ID: 37121446)
21. Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.
Chen W; Geng D; Chen J; Han X; Xie Q; Guo G; Chen X; Zhang W; Tang S; Zhong X
Cancer Cell Int; 2024 Mar; 24(1):101. PubMed ID: 38462618
[TBL] [Abstract][Full Text] [Related]
22. Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism.
Li Z; Wu X; Chen S; Zhong J; Qiu X; Kpegah JKSK; Shi K; Can L; Zhang X; Yin M; Xie H; Su J; Zhou J
Genomics; 2023 May; 115(3):110634. PubMed ID: 37121446
[TBL] [Abstract][Full Text] [Related]
23. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
24. Crk and CrkL as Therapeutic Targets for Cancer Treatment.
Park T
Cells; 2021 Mar; 10(4):. PubMed ID: 33801580
[TBL] [Abstract][Full Text] [Related]
25. The role of CT10 regulation of kinase-like in cancer.
Guo C; Liu S; Sun MZ
Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052
[TBL] [Abstract][Full Text] [Related]
26. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
Sattler M; Salgia R
Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
[TBL] [Abstract][Full Text] [Related]
27. Crk family adaptors-signalling complex formation and biological roles.
Feller SM
Oncogene; 2001 Oct; 20(44):6348-71. PubMed ID: 11607838
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
